Conditions: Essential Hypertension
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 665
Healthy volunteers: no

Brief summary:
Aim of this study is to compare the blood pressure lowering effect of a new drug formulation of eprosartan. Eprosartan belongs to a class of blood pressure lowering agents used worldwide since years with proven efficacy. The new formulation is compared to the currently marketed eprosartan tablet. Equivalent efficacy in blood pressure lowering effects should be demonstrated.

Detailed description:

Arms:
arm 1: Eprosartan + Placebo Eprosartan Mesylate arm 2: Eprosartan Mesylate + Placebo Eprosartan

Interventions: intervention 1: Eprosartan intervention 2: Eprosartan Mesylate intervention 3: Placebo Eprosartan mesylate intervention 4: Placebo Eprosartan
Intervention descriptions: intervention 1: Eprosartan 450 mg intervention 2: Eprosartan mesylate 600 mg intervention 3: Placebo Eprosartan mesylate intervention 4: Placebo Eprosartan

Protocol document: